Argireline®-C Antiwrinkle Treatment in a Capsule

Efficacy Testing

In clinical testing, emulsion containing 10% of Acetyl Hexapeptide-3 (ARGIRELINE®)  solution applied   twice a day around eyes. It was observed that severity of wrinkles around eyes decreased up to 17% after 15days of treatment and up to 27% after 30days of treatment, sustaining the proposed biochemical mechanism hypothesis.

In VIVO Testing

The skin replicas below show the improvement in facial smoothness at 30 days post Acetyl Hexapeptide-3 (ARGIRELINE®) treatment, compared with results obtained without the incorporation of Acetyl Hexapeptide-3 (ARGIRELINE®) solution into the test cream.